Ontario, OTT – BioTalent Canada, the national non-profit dedicated to strengthening Canada’s bio-economy workforce, has been named a 2025 Employer of Choice by Canadian HR Reporter (CHRR). This marks the first time BioTalent Canada… Read More
Acquisition expands AbbVie’s psychiatry pipeline with the addition of a next-generation psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD). NORTH CHICAGO, Ill – AbbVie … Read More
Vancouver, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical… Read More
Earlier this month at the 27th Annual Life Sciences of British Columbia Awards, PHC Ventures was named Strategic Partner of the Year, a recognition of their role in shaping the future… Read More
Exclusive commercial rights secured for the nanobody-based CD22 binder for next-generation CAR applications like in vivo CAR-T and CAR-M CD22 nanobody binder offers potential advantages compared to traditional antibody formats… Read More
